--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Hapmed" developer_entity: "AVANZ" bundle_id: "br.com.hapvida.hapmed.app" app_store_id: "1526679117" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2025-06-03" report_date: "2026-08-23" last_verified: "2026-08-23T00:00:00.000Z" report_version: "2.9.1" total_reviews: 0 confidence: "low" confidence_score: 0 data_age_days: 81 momentum_velocity: "zombie" intelligence_version: 3 tags: ["medical", "free", "mobile app", "app review", "app analysis", "surgeons", "medical", "professionals"] canonical_url: "https://marlvel.ai/apps/hapmed" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Hapmed Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free > **TL;DR:** Hapmed is a medical app by AVANZ, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Hapmed is a medical app by AVANZ. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | AVANZ | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0/1.0) | | **Data Age** | 81d | ## Metadata & Market Performance - **Publisher:** AVANZ - **Category:** Medical - **Target Audience:** Surgeons and medical professionals requiring mobile access to patient diagnostic imaging and surgical schedules. - **Platforms:** iOS - **Version Reviewed:** 2.9.1 - **Report Date:** 2026-08-23 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0/1.0) - **App Store ID (iOS):** 1526679117 - **Bundle ID:** br.com.hapvida.hapmed.app - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-23 ## Executive Snapshot **What it is:** Hapmed is a medical utility for surgeons to view surgical schedules and diagnostic imaging on iOS. **Why users hire it:** The platform removes the administrative friction of accessing patient X-rays, MRIs, and CT scans outside of hospital workstations. ## App DNA (Features & Intent) - **[Standard] Surgical Schedule Management:** Centralized view of upcoming medical procedures and surgeon agendas, serving as a B2B utility for hospital staff workflows. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Medical Imaging Viewer:** In-app access to patient diagnostic results including X-ray, MRI, and CT scans, reducing administrative friction for surgeons. ## Market Position {#market-position} Hapmed occupies a niche medical utility segment with no recent updates for 446 days. The lack of active development relative to the broader medical software market signals a sunset posture, as the product has not received a major update in over a year. ## Monetization Strategy - **Model:** Free - **Tiers:** Free access for authorized medical professionals - **Analysis:** Hapmed functions as a free utility, likely supported by institutional B2B agreements rather than direct consumer monetization. ## SWOT Analysis {#swot} **Core Strengths:** - Centralized surgical schedule management - In-app access to diagnostic imaging **Growth Levers:** - Integration with hospital EHR systems - Support for DICOM-standard mobile viewing ## Recent Changes (v2 → v3) {#recent-changes} The outlook for Hapmed has shifted from stable to declining due to a prolonged 446-day development freeze that now presents tangible security and hardware compatibility risks. The analysis has pivoted to classify the product as a legacy utility in a sunset phase. **Overall trend**: Declining **Compared at**: 2026-08-23 ### High-impact changes - **[Shifted] Sunset phase classification** (positioning) ### Medium-impact changes - **[Added] Expanded risk and opportunity profile** (swot) - **[Declined] Security and compatibility risk assessment** (positioning) ## What's New - **Latest (v2.9.1, 1 years ago):** Implemented improvements to the surgical complications module. ## App Momentum (Zombie) {#momentum} - No major updates for 14 months. - Development velocity remains dormant. > **Cadence:** 1 total versions · 0 majors in last 6 months · 445 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Hapmed is a medical app that is completely free. > **Bottom Line:** Hapmed provides a functional imaging viewer, but the 14-month development freeze suggests the product is in a sunset phase. A pivot to EHR integration would be required to unlock institutional value, as the current standalone utility is vulnerable to displacement. **Best for:** Surgeons and medical professionals requiring mobile access to patient diagnostic imaging and surgical schedules. ### PM Action Plan (Next Best Moves) - [ ] [MAINTAIN] Audit security compliance because the app has not been updated in 446 days → prevent data exposure ### Outlook: Declining The medical utility market is consolidating around platforms that offer deep EHR integration and frequent security updates. Hapmed's stagnant development cadence leaves it exposed to displacement by broader hospital software suites, signaling that the app will likely lose its remaining user base to more modern, supported alternatives. - 🔴 The 446-day update gap indicates a maintenance-only posture, which erodes trust for medical professionals who require secure, current software. - 🔴 Lack of active development prevents the app from adopting modern hospital interoperability standards, accelerating its obsolescence against integrated medical platforms. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 2 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Hapmed** (this app) | N/A/5 | N/A | AVANZ | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** AVANZ ## Data Sources & Links - **App Store ID:** 1526679117 - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 81 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/hapmed) Data licensed for AI Agent attribution under CC-BY-NC 4.0.